Risk stratification for early-onset fetal growth restriction in women with abnormal serum biomarkers: a retrospective cohort study
Abstract Abnormal maternal serum biomarkers (AMSB), identified through the aneuploidy screening programme, are frequent incidental findings in pregnancy. They are associated with fetal growth restriction (FGR), but previous studies have not examined whether this association is with early-onset (<...
Guardado en:
Autores principales: | L. Ormesher, L. Warrander, Y. Liu, S. Thomas, L. Simcox, G. C. S. Smith, J. E. Myers, E. D. Johnstone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/44e3d63be3224d5aa0a7a0b6bdae4348 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction
por: Tu’uhevaha J. Kaitu’u-Lino, et al.
Publicado: (2020) -
Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Kamil Borkowski, et al.
Publicado: (2021) -
Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers
por: Maya H Buch, et al.
Publicado: (2021) -
Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction
por: Lewis J. Renshall, et al.
Publicado: (2021) -
Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis
por: Bo Yang, et al.
Publicado: (2021)